Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)

NCT02327078

Conditions
Adnexal Diseases, Astrocytoma, B-cell Malignancies, +53 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • UCSF - University of California San Francisco San Francisco, California, United States
View all 24 locations
View Trial Details
Completed

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

NCT00049595

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations
  • Canberra Hospital Garran, Australian Capital Territory, Australia
  • Nepean Cancer Care Centre at Nepean Hospital Kingswood, New South Wales, Australia
  • Westmead Institute for Cancer Research at Westmead Hospital Westmead, New South Wales, Australia
  • Princess Alexandra Hospital Brisbane, Queensland, Australia
View all 140 locations
View Trial Details
Completed

Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

NCT02956382

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
  • Seattle Cancer Care Alliance Seattle, Washington, United States
View Trial Details
Completed

A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)

NCT03144674

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • University of Alabama At Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Arizona Oncology Associates Tempe, Arizona, United States
  • Torrance Health Association Redondo Beach, California, United States
  • Sansum Clinic Santa Barbara, California, United States
View all 86 locations
View Trial Details
Completed

Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.

NCT01996865

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Local Institution - 055 Tucson, Arizona, United States
  • Local Institution - 077 Little Rock, Arkansas, United States
  • Local Institution - 079 Berkeley, California, United States
  • Local Institution - 142 Concord, California, United States
View all 126 locations
View Trial Details
Completed

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

NCT03884556

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +27 more
Locations
  • UC Irvine Cancer Center Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 16 locations
View Trial Details

Related conditions